Hugo Solvet
Stock Analyst at Exane BNP Paribas
(0.95)
# 3,962
Out of 5,070 analysts
14
Total ratings
58.3%
Success rate
-6.3%
Average return
Main Sectors:
Stocks Rated by Hugo Solvet
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FMS Fresenius Medical Care AG | Downgraded: Sell | $20 | $21.41 | -7.05% | 1 | Jul 28, 2026 | |
| EPA: BIM bioMérieux S.A. | Downgraded: Hold | €100.00 | €87.20 | +14.68% | 1 | Jan 28, 2026 | |
| BIT: DIA DiaSorin S.p.A. | Upgraded: Hold | n/a | $79.50 | - | 2 | Jan 28, 2026 | |
| SWX: SOON Sonova Holding AG | Reiterated: Sell | CHF 215.00 → CHF 195.00 | CHF 278.60 | n/a | 3 | Oct 20, 2025 | |
| AMS: PHIA Koninklijke Philips N.V. | Upgraded: Buy | €23.21 → €29.00 | €23.12 | n/a | 3 | Feb 25, 2025 | |
| ETR: SHL Siemens Healthineers AG | Upgraded: Buy | €63.00 | €41.44 | n/a | 1 | Feb 7, 2024 | |
| RGEN Repligen | Initiated Coverage: Buy | $330 | $178.88 | n/a | 1 | Oct 14, 2021 | |
| ETR: FME Fresenius Medical Care AG | Downgraded: Hold | €65.00 | €39.46 | n/a | 1 | Feb 4, 2021 | |
| QGEN Qiagen | Upgraded: Buy | $56 | $48.90 | n/a | 1 | Aug 14, 2020 |
Fresenius Medical Care AG
Jul 28, 2026
Downgraded: Sell
Price Target: $20
Current: $21.41
Upside: -7.05%
bioMérieux S.A.
Jan 28, 2026
Downgraded: Hold
Price Target: €100.00
Current: €87.20
Upside: +14.68%
DiaSorin S.p.A.
Jan 28, 2026
Upgraded: Hold
Price Target: n/a
Current: $79.50
Upside: -
Sonova Holding AG
Oct 20, 2025
Reiterated: Sell
Price Target: CHF 215.00 → CHF 195.00
Current: CHF 278.60
Upside: n/a
Koninklijke Philips N.V.
Feb 25, 2025
Upgraded: Buy
Price Target: €23.21 → €29.00
Current: €23.12
Upside: n/a
Siemens Healthineers AG
Feb 7, 2024
Upgraded: Buy
Price Target: €63.00
Current: €41.44
Upside: n/a
Repligen
Oct 14, 2021
Initiated Coverage: Buy
Price Target: $330
Current: $178.88
Upside: n/a
Fresenius Medical Care AG
Feb 4, 2021
Downgraded: Hold
Price Target: €65.00
Current: €39.46
Upside: n/a
Qiagen
Aug 14, 2020
Upgraded: Buy
Price Target: $56
Current: $48.90
Upside: n/a